# Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD

> **NCT05882487** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 9 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **GENETIC:** KL002 injection solution

## Key facts

- **NCT ID:** NCT05882487
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2023-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05882487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05882487, "Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05882487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*